IP Library Granted Patent US 8,821,451
Granted Patent B2
US 8,821,451 · App. 13/650,712 · Granted Sep 2, 2014

Medicament delivery device

Inventor: Mattias Daniel (Stockholm, SE)
Assignee: SHL Group AB
A61M5/2033A61M2205/582A61M5/3157A61M2005/2013A61M2205/583A61M5/3202A61M2205/581
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,821,451
App. No.
13/650,712
Granted
Sep 2, 2014
Kind
B2
Abstract

The present invention relates to a medicament delivery device comprising a drive means configured to act on a medicament container for expelling a medicament; a holding means configured to hold said drive means in a pre-tensioned state; an activation means configured to interact with said holding means for releasing said drive means from the pre-tensioned state; wherein the device further comprises feedback means configured to interact both with said holding means and with said drive means for generating an audible and/or tactile and/or visual signal indicating that the medicament has been completely expelled.

Claims (23)

1. An automatic medicament delivery device that notifies a user of complete expulsion of medicament from a medicament container comprising,

a) a tubular housing having a proximal end and a distal end;

b) a container holder coaxially arranged and fixed on the proximal end of the tubular housing;

c) a medicament container lodged within the container holder comprising a predetermined volume of medicament, a slidable stopper and a delivery member;

d) a tubular extension member having an inner surface;

e) a hollow tubular plunger rod having an outer surface slidably engaged within the inner surface of the tubular extension member, where the plunger rod has a proximal wall configured to engage and drive the slidable stopper in a proximal direction upon activation of the medicament delivery device;

f) a first resilient member positioned inside the plunger rod, wherein the first resilient member is in a pre-tensioned state exerting a force on the proximal end of the plunger rod prior to activation;

g) an engaging surface on the outer surface of the plunger rod;

h) a resilient tongue projecting radially inward from the tubular extension member and releasably engaged with the engaging surface to prevent axial movement of the plunger rod in the proximal direction and to maintain the resilient member in the pre-tensioned state;

i) a tubular operation member rotatably and coaxially arranged on the tubular extension member and having an inner surface engaged with the resilient tongue;

j) an activation member slidably positioned within the tubular housing and rotatably fixed relative to the tubular housing, where the activation member is configured to engage the tubular operation member to activate the device;

k) a second resilient member engaged with and exerting a biasing force on the activation member in a proximal direction; and

l) a signal generating member that is configured to transmit an audible sound after activation to signal complete expulsion of the medicament from the medicament container through the delivery member.

2. The medicament delivery device of claim 1 further characterized in that the signal generating member comprises a transversal wall positioned a distance D from the inner distal surface prior to activation, wherein the audible signal is caused by the transversal wall traveling distally the distance D and hitting the inner distal surface.

3. The medicament delivery device of claim 1 further characterized in that the activation member has an annular contact member at a proximal end and distal end configured to engage and move the tubular operation member when a user pushes the annular contact member against an injection site.

4. The medicament delivery device of claim 3 further comprising a cap configured to attach to the distal end of the tubular housing abutting the annular contact member.

5. The medicament delivery device of claim 1 further characterized in that the activation member is configured to be achieve three states, an activated state, a delivery state and a final locked state.

6. The medicament delivery device of claim 5 further characterized in that the final locked state prevents unintentional availability of the delivery member after expulsion of the medicament.

7. The medicament delivery device of claim 1 wherein the medicament container is a syringe and the delivery member is a needle.

8. The medicament delivery device of claim 1 further characterized in that the second resilient member is in a pre-tensioned state when the activation member is in the activation state.

9. The medicament delivery device of claim 1 further characterized in that the engaging surface is a groove or cut-out.

10. The medicament delivery device of claim 9 further characterized in that the resilient tongue comprises a radial inward protrusion configured to releasably fit into the groove or cut-out.

11. The drive mechanism of claim 1 further characterized in that the signal generating member partially surrounds the outer surface of the plunger rod.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2019
From: SHL GROUP AB
To: SHL MEDICAL AG
Reel/Frame 048211/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2015
From: DANIEL, MATTIAS
To: SHL GROUP AB
Reel/Frame 036863/0852 →
Priority Claims (1)
SE 1050307 · Mar 31, 2010 · national
Continuity (3)
Continuation 13636241
Provisional Application 61319453 · Mar 31, 2010
Related Publication 20130041323A1 · Feb 14, 2013